Max Robotics — Global Service Robot Directory + US Certification

About

Dr. Akihiro Goriki is a pioneering urologic surgeon whose research focuses on advancing robotic surgery for urologic oncology, particularly in prostate and adrenal cancer treatment. His work centers on evaluating the safety, efficacy, and functional outcomes of robotic-assisted procedures, including radical prostatectomy, partial nephrectomy, and adrenalectomy. Dr. Goriki’s major contributions include demonstrating the real-world effectiveness of the hinotori™ Surgical Robot System in urologic tumor surgeries (2024, 8 citations) and identifying preoperative high serum total testosterone levels as a predictor of preserved postoperative sexual function after nerve-sparing robot-assisted radical prostatectomy (2024, 3 citations). His propensity-matched analyses have also clarified clinical characteristics and predictors of long-term postoperative urinary incontinence after robot-assisted radical prostatectomy (2024, 6 citations), and compared treatment outcomes of robotic versus laparoscopic adrenalectomy (2025, 3 citations). These findings directly inform surgical decision-making and patient counseling, enhancing postoperative quality of life. Dr. Goriki’s work is instrumental in refining robotic surgical techniques and expanding their application in Japan, where robotic adrenalectomy was recently added to insurance coverage. His research is widely cited by urologists and robotic surgeons seeking evidence-based guidance on optimizing functional recovery and surgical outcomes.